HemoRea
The computed 12-month bankruptcy probability of HemoRea is 0.4% (very low). The 2021 annual accounts show equity of €30k and a net result of €8k. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €30k |
| Net result | €8k |
| Active | 5 yrs |
| Board | 1 |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Fiscal year | 2021 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €8k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | €3k |
| Dividends | €800 |
| Total assets | €41k |
| Equity | €30k |
| Debt | €11k |
| of which ≤ 1y | €11k |
| of which > 1y | - |
| Working capital | €30k |
| Employees (FTE) | - |
| 2021 | |
|---|---|
| Current ratio | 3.85 |
| Quick ratio | 3.85 |
| Working capital ratio | 74.1% |
| Solvency | 74.1% |
| Debt / equity | 0.35 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 20.5% |
| ROE | 27.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2021 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €41k |
| Current assets | 29/58 | €41k |
| Amounts receivable within one year | 40/41 | €3k |
| Cash & bank | 54/58 | €38k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €41k |
| Equity | 10/15 | €30k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €28k |
| Amounts payable | 17/49 | €11k |
| Amounts payable within one year | 42/48 | €11k |
| Income statement | ||
| Gross operating margin | 9900 | €15k |
| Operating result | 9901 | €12k |
| Financial charges | 65 | €956 |
| Result before taxes | 9903 | €11k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €8k |
| Result to be appropriated | 9905 | €8k |
-
Nathalie LAYIOSDirectorState Gazette act 25056714 (02-05-2025)Current01-01-2025 → present
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 06-10-2020 |
| Status | Active |
| Postal code | 5100 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92322D0366/00E003 | Wallonia | 852 m² | 1 · 108 m² | 7.0 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
02-05-2025 Nathalie LAYIOS appointed as director
- Nathalie LAYIOS, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nathalie LAYIOS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-01-01",
"evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire d\u00E9cide la nomination de Madame Nathalie LAYIOS comme administrateur \u00E0 titre gratuit pour une dur\u00E9e illimit\u00E9e \u00E0 partir du 1er janvier 2025.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "PGujnef",
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-05-02",
"filing_date": "2025-01-01",
"act_kind_objet": "NOMINATION ADMINISTRATEUR A TITRE GRATUIT"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-01-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0755.776.191",
"name_full": "HemoRea",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Layios",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | HemoRea |